Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use

…, MR McClung, PD Miller, WP Olszynski… - Endocrine …, 2005 - academic.oup.com
All therapies currently recommended for the management of osteoporosis act mainly to
inhibit bone resorption and reduce bone remodeling. PTH and its analog, teriparatide […

Bone strength: the whole is greater than the sum of its parts

…, AB Hodsman, R Josse, S Kaiser, WP Olszynski… - Seminars in arthritis and …, 2006 - Elsevier
OBJECTIVE: To summarize the current knowledge regarding the various determinants of
bone strength. METHODS: Relevant English-language articles acquired from Medline from …

Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment

WP Olszynski, KS Davison, JD Adachi, JP Brown… - Clinical …, 2004 - Elsevier
Background: Osteoporosis and fragility fractures in men account for substantial health care
expenditures and decreased quality of life. Objective: This article reviews the most current …

Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study

…, L Pickard, CC Kennedy, JC Prior, WP Olszynski… - Cmaj, 2009 - Can Med Assoc
Background: Fractures have largely been assessed by their impact on quality of life or health
care costs. We conducted this study to evaluate the relation between fractures and mortality…

Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions

…, JJ Kaufman, R Lorenc, PD Miller, WP Olszynski… - Journal of Clinical …, 2008 - Elsevier
Dual-energy X-ray absorptiometry (DXA) is commonly used in the care of patients for
diagnostic classification of osteoporosis, low bone mass (osteopenia), or normal bone density; …

Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada.

…, AA Cividino, CA McFarlane, WP Olszynski… - The Journal of …, 1996 - europepmc.org
Methods A retrospective study of all patients with osteoarthritis of the knee treated with hylan
by 5 Canadian clinicians over a period of 2.5 years. Results A total of 1537 injections were …

Development and validation of the spondyloarthritis research consortium of Canada (SPARCC) enthesitis index

…, S Morrow, K Shojania, WP Olszynski… - Annals of the …, 2009 - ard.bmj.com
WP Maksymowych1, … WP Olszynski4, … Professor WP Maksymowych, Department of Medicine,
562 Heritage Medical Research Building, University of Alberta, Edmonton, Alberta T6G 2S2 …

The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada

…, S Poliquin, JC Prior, DA Hanley, WP Olszynski… - Osteoporosis …, 2001 - Springer
Health-related quality of life (HRQL) was examined in relation to prevalent fractures in 4816
community-dwelling Canadian men and women 50 years and older participating in the …

Fracture risk remains reduced one year after discontinuation of risedronate

NB Watts, A Chines, WP Olszynski… - Osteoporosis …, 2008 - Springer
One year after discontinuation of three year’s treatment with risedronate, BMD decreased at
the lumbar spine and femoral neck and bone turnover markers returned to control group …

Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: Cross‐sectional …

…, JP Brown, A Tenenhouse, WP Olszynski… - Journal of bone and …, 2003 - academic.oup.com
This cross‐sectional cohort study of 5566 women and 2187 men 50 years of age and older
in the population‐based Canadian Multicentre Osteoporosis Study was conducted to …